Richard Gregory

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 2

Top Topics

Angiotensin Converting Enzyme

Coronavirus Disease

Top Venues

Science (New York, N.Y.)

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin E West, Carmen Mirabelli, Charles J Zhang, Eva-Maria Nichols, Nazish Malik, Richard Gregory, Marcus Bantscheff, Sonja Ghidelli-Disse, Martin Kolev, Tristan Frum, Jason R Spence, Jonathan Z Sexton, Konstantinos D Alysandratos, Darrell N Kotton, Stefania Pittaluga, Jack Bibby, Nathalie Niyonzima, Matthew R Olson, Shahram Kordasti, Didier Portilla, Christiane E Wobus, Arian Dominic John Laurence, Michail S Lionakis, Claudia Kemper, Behdad Afzali, Majid Kazemian
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Science immunology 6 (58) (2021)
Dean S Tyler, Johanna Vappiani, Tatiana Cañeque, Enid Y N Lam, Aoife Ward, Omer Gilan, Yih-Chih Chan, Antje Hienzsch, Anna Rutkowska-Klute, Thilo Werner, Anne J Wagner, Dave Lugo, Richard Gregory, Cesar Ramirez Molina, Neil Garton, Christopher R Wellaway, Susan Jackson, Laura MacPherson, Margarida Figueiredo, Sabine Stolzenburg, Charles C Bell, Colin House, Sarah-Jane Dawson, Edwin D Hawkins, Gerard Drewes, Rabinder K Prinjha, Raphaël Rodriguez, Paola Grandi, Mark A Dawson
Click chemistry enables preclinical evaluation of targeted epigenetic therapies. Science (New York, N.Y.) 356 (6345) (2017)